➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Merck
Mallinckrodt
McKinsey
Dow

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 9,179,899

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,179,899
Title:Implantable device
Abstract: In an implantable device (1) for use in the human and/or animal body for closure or partial closure of defect openings (2), cavities, organ passages etc or for providing a defined communicating opening between walls, organs, cavities etc comprising a carrier structure (17) which in a primary form has a large ratio of length to transverse extent along an axis (x) and in a secondary form has a smaller ratio of length to transverse extent along the axis (x), wherein the carrier structure (17) has a proximal and a distal portion (10, 11) and is formed in the manner of a weft and/or mesh and/or layered cloth and/or gauze, at least the one portion (11) in the secondary form has a first part (14) facing outwardly away from the other portion (10) or towards same and a second part (13) which deploys first from the primary form into the secondary form and which is folded back in a direction towards the other portion (10) or inwardly on to the first part (14).
Inventor(s): Freudenthal; Franz (La Paz, BO)
Assignee: PFM MEDICAL AG (Cologne, DE)
Application Number:11/973,267
Patent Claims:see list of patent claims

Details for Patent 9,179,899

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22   Start Trial PFM MEDICAL AG (Cologne, DE) 2026-10-05 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Mallinckrodt
McKesson
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.